Systemic Therapy - Whole Body

University Hospitals Seidman Cancer Center Utilizes Targeted Therapies to Treat Patients with Renal Cancer

Often, conventional or clear cell, renal cancer, does not respond to traditional chemotherapy, but does respond to immunotherapy or drugs referred to as “targeted therapies”. Recent clinical research studies have discovered these therapies (sunitinib, temsirolimus, sorafenib and everolimus) to treat certain kidney cancers. UH Seidman Cancer Center physicians have been offering these treatments to patients since they were first available.

Interleukin 2 Therapy

Our team is one of the few in the country that offers interleukin 2 or IL-2. Interleukin 2 is the only systemic therapy known to cure kidney cancer after it has spread to other regions of the body. Antibodies that target molecules on the outside of the kidney cancer cells are also being researched and studied.

Advanced Radiosurgery Procedures

UH Seidman Cancer Center physicians sometimes use radiation therapy as the primary form of treatment for patients who are not physically well enough to have surgery, although kidney tumors are often less sensitive to radiation. Our team of physicians leads the world as one of the first to evaluate and publish the use of radiosurgery for the treatment of kidney tumors. Patients who are appropriate candidates for this procedure are treated without making incisions.

Make an Appointment

Schedule your appointment with a specialist at University Hospitals.
1-866-UH4-CARE (1-866-844-2273)

More Scheduling Options

Need to Refer a Patient?

Click here for Patient Referrals